As of 2025-01-21, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 10.89 USD. This relative valuation is based on P/E multiples. With the latest stock price at 37.74 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -71.2%.
The range of the Relative Valuation is 1.38 - 29.89 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 27.6x | 18.2x |
| Forward P/E multiples | 13.1x - 20.6x | 19.9x |
| Fair Price | 1.38 - 29.89 | 10.89 |
| Upside | -96.3% - -20.8% | -71.2% |
| Date | P/E |
| 2025-01-13 | 34.74 |
| 2025-01-10 | 34.67 |
| 2025-01-08 | 35.20 |
| 2025-01-07 | 34.61 |
| 2025-01-06 | 34.26 |
| 2025-01-03 | 34.14 |
| 2025-01-02 | 33.69 |
| 2024-12-31 | 33.44 |
| 2024-12-30 | 34.13 |
| 2024-12-27 | 34.38 |
| 2024-12-26 | 33.55 |
| 2024-12-24 | 32.92 |
| 2024-12-23 | 32.91 |
| 2024-12-20 | 32.76 |
| 2024-12-19 | 33.08 |
| 2024-12-18 | 32.79 |
| 2024-12-17 | 33.50 |
| 2024-12-16 | 33.74 |
| 2024-12-13 | 33.45 |
| 2024-12-12 | 33.44 |
| 2024-12-11 | 34.08 |
| 2024-12-10 | 33.98 |
| 2024-12-09 | 33.92 |
| 2024-12-06 | 34.37 |
| 2024-12-05 | 34.21 |
| 2024-12-04 | 34.36 |
| 2024-12-03 | 34.24 |
| 2024-12-02 | 34.50 |
| 2024-11-29 | 33.82 |
| 2024-11-27 | 34.21 |
| 2024-11-26 | 33.42 |
| 2024-11-25 | 33.38 |
| 2024-11-22 | 33.50 |
| 2024-11-21 | 33.13 |
| 2024-11-20 | 33.40 |
| 2024-11-19 | 32.86 |
| 2024-11-18 | 32.60 |
| 2024-11-15 | 32.89 |
| 2024-11-14 | 33.46 |
| 2024-11-13 | 34.93 |
| 2024-11-12 | 34.98 |
| 2024-11-11 | 33.86 |
| 2024-11-08 | 33.85 |
| 2024-11-07 | 33.66 |
| 2024-11-06 | 34.91 |
| 2024-11-05 | 32.13 |
| 2024-11-04 | 32.09 |
| 2024-11-01 | 31.41 |
| 2024-10-31 | 31.51 |
| 2024-10-30 | 32.25 |